Shiro Koizume

No ORCID on file · 4 papers in corpus
other 2024
Tissue factor pathway inhibitor 2 as a serum biomarker for endometrial cancer: a single-center retrospective study
BMC cancer ·doi:10.1186/s12885-024-12827-0

BACKGROUND: Endometrial cancer is the most common gynecological malignancy; however, there is no useful blood diagnostic biomarker. This study aimed to determine the utility of tissue factor pathway inhibitor 2 (TFPI2), a biomarker of ovari…

review 2016
1Biomarkers in CanCer 2015:7(s2) Tissue Factor–Factor VII Complex As a Key Regulator of Ovarian Cancer Phenotypes Supplementary Issue: Signaling Pathways as Biomarkers

ABSTR ACT: Tissue factor (TF) is an integral membrane protein widely expressed in normal human cells. Blood coagulation factor VII (fVII) is a key enzyme in the extrinsic coagulation cascade that is predominantly secreted by hepatocytes and…

review 2015
Tissue Factor-Factor VII Complex As a Key Regulator of Ovarian Cancer Phenotypes
Biomarkers in cancer ·doi:10.4137/BIC.S29318

Tissue factor (TF) is an integral membrane protein widely expressed in normal human cells. Blood coagulation factor VII (fVII) is a key enzyme in the extrinsic coagulation cascade that is predominantly secreted by hepatocytes and released i…

lab-animal 2013
Annexin A4 is involved in proliferation, chemo-resistance and migration and invasion in ovarian clear cell adenocarcinoma cells
PloS one ·doi:10.1371/journal.pone.0080359

Ovarian clear cell adenocarcinoma (CCC) is the second most common subtype of ovarian cancer after high-grade serous adenocarcinomas. CCC tends to develop resistance to the standard platinum-based chemotherapy, and has a poor prognosis when …